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,To the Editor:
We thank Fujita and colleagues for their comments
and this opportunity to discuss the questions raised
regarding our recent investigation on bacterial DNA
translocation in patients with cirrhosis.
Our main line of research is focused on the study of
bacterial translocation (BT) in patients with decompen-
sated cirrhosis. Approximately, 30% of these patients
show the simultaneous presence of bacterial DNA (bac-
tDNA) in blood and ascitic ﬂuid (AF) [1,2] and a recent
study in an experimental model of CCl4-induced cirrho-
sis with ascites positively correlated this ﬁnding with the
identiﬁcation of bactDNA in mesenteric lymph nodes
[3]. However, and related to the ﬁrst question, we re-
cently conducted a study in which bactDNA detection
and the associated inﬂammatory response was evaluated
in patients with spontaneous bacterial peritonitis (SBP).
In this study, a total series of 22 patients with SBP was
analyzed. All 22 cases showed the presence of bacterial
genomic fragments as revealed by PCR of the 16SrRNA
gene. Identiﬁcations by DNA sequencing analysis in pa-
tients with culture-positive SBP corresponded to those
isolated by microbiological culture in all cases, except
for one patient that showed a Staphylococcus aureus
by sequencing analysis and a Streptococcus pneumoniae
by microbiological culture [4].
Regarding experimental procedures, control experi-
ments are normally run over all DNA extraction Kit
solutions as well as PCR mastermix reagents. Speciﬁcity
experiments are always completed with a 10 pg-spike of
Escherichia coli DNA to determine the presence of
inhibitors in the media. In addition, all solutions and re-
agents are handled in sterile air-ﬂow chambers previ-
ously irradiated with UV light, and sterile plastic
material and ﬁlter tips are used all along the technique
of DNA isolation and ampliﬁcation. Finally, in all
PCR reactions, two negative controls are always run:
one with sterile water instead of sample templates and
one with PCR mastermix alone. We are aware of thestudy by Heininger A et al. in which, as pointed out
by Fujita T, 16.6% false-positive results are present
when DNA is isolated from healthy volunteers with a
commercially available kit [5]. DNA isolation kit used
in that study (Puregene Whole Blood Kit, Biozym Diag-
nostics) is not the same as the one we usually handle
(QiAmp Blood Minikit, QIAgen). Also, the set of prim-
ers used to perform PCR reactions are also diﬀerent in
that study. Therefore, it is diﬃcult for us to compare
or discuss on someone else’s reported contamination
rates.
A signiﬁcantly increased cytokine response is pres-
ent in patients with presence of bactDNA [6,7]. De-
spite this increment, values have never reached lg/m
levels. This is, as suggested, a typing mistake. Al
cytokine determinations were measured in pg/mL
We apologise for this confusion and thank Dr. Fujita
and colleagues for their appreciation. Indeed, in the
previously mentioned study on the inﬂammatory re-
sponse in patients with advanced cirrhosis and ascites
extended results on several cytokine levels can be fol-
lowed in diﬀerent clinical settings.
Endotoxin is a diﬃcult to measure parameter. LPS
traces can be detected in serum from patients with pres-
ence of Gram-positive microorganisms. We consider
that reported diﬀerences in endotoxin levels simply re-
ﬂect intrinsic characteristics of both subgroups of bacte-
rial species and do not allow discussion about its
biological activity. For this purpose lipopolysaccharide
binding protein (LBP) measurement has been proposed
instead [8]. However, endotoxin, DNA or peptidogly-
can, among others bacterial products, stimulate the in-
nate immune system and induce the liberation of
proinﬂammatory cytokines and nitric oxide, and these
factors indeed have clinical consequences. The detection
of high levels of endotoxin or the above-mentioned bac-
terial products identify a subgroup of patients with evi-
dences of bacterial translocation, and this may aﬀect
prognosis [9].
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Antioxidants plus corticosteroids in the treatment of severe acute
alcoholic hepatitis: The question is still open
To the Editor:
We read with interest the article by Stewart et al. [1].
The authors concluded that the treatment of severe acute
alcoholic hepatitis (AAH) with antioxidants (AO) alone
or with corticosteroids (C) did not improve survival at 6
months. Combining AO with C is attractive, since exces-
sive TNFa levels in AAH are more damaging on hepato-
cytes when glutathione reserves are depleted by chronic
alcohol intake [2]. The negative results of this work should
not oblige us to hastily abandon this strategy. The study
had several limits: (i) Sample size calculation was based
on the hypothesis of a 40% survival improvement with
AO, which seems to be much too optimistic; (ii) AAH
was only histologically conﬁrmed in 63% of the cases;
(iii) surprisingly, 44% (n = 34/77) of the patients with a
Maddrey scoreP32 were not treated with corticosteroids,
for reasons not speciﬁed; and (iv) two stratiﬁcations (gen-
der and corticosteroids) were applied prior to randomiza-
tion for AO, resulting in eight small groups, with two
without any treatment. Assessment of survival was per-
formed by pooling 34 patients treated by C or not treated,
compared with 36 patients treated with AO or placebo,
plus C or no treatment. This boils down to testing two
hypotheses at the same time (AO vs. C and AO + C vs.
C), which is not appropriate – especially since the C vs.
AO strategy has been shown to be ineﬀective [3]. Hence,
we believe that it is still worth performing a study which
compares a combination therapy (C + AO) with C alone
in severe AAH patients.
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